Bio-Rad Laboratories (BIO) EBITDA Margin (2009 - 2026)
Bio-Rad Laboratories' (BIO) quarterly EBITDA Margin came in at 11.15% in Q2 2026, down 68.0% year-over-year from 34.85% in Q2 2025, and up 93.64% quarter-over-quarter from 5.76% in Q1 2026.
Powered by 
Analysis
Bio-Rad Laboratories (BIO) EBITDA Margin (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported EBITDA Margin for 18 consecutive years, with 11.15% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA Margin fell 68.0% year-over-year to 11.15% in Q2 2026; TTM through Jun 2026 was 2.05%, a 670.0% decrease from a year earlier, with the FY2025 full-year figure at 1.83%, down 865.0% from the prior year.
- EBITDA Margin was 11.15% for Q2 2026 at Bio-Rad Laboratories, up from 5.76% in the prior quarter.
- Over five years, EBITDA Margin peaked at 20.91% in Q1 2022 and troughed at 17.15% in Q4 2025.
- A 5-year average of 10.39% and a median of 11.49% in 2026 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin soared 703 bps in 2022 and sank 2589 bps in 2025, its largest moves.
- Over 5 years, EBITDA Margin stood at 16.25% in 2022, then dropped by 14 bps to 13.99% in 2023, then plunged by 38 bps to 8.73% in 2024, then plunged by 296 bps to 17.15% in 2025, then jumped by 165 bps to 11.15% in 2026.
- The last three EBITDA Margin figures came in at 11.15% (Q2 2026), 5.76% (Q1 2026), and 17.15% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | 17.99% |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 23.64% |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | 21.14% |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | 12.24% |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 23.13% |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 11.15% |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | 6.85% |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | -12.95% |
| 10 | Bruker | 8.30 Bn | 8.09 Bn | 416.00 Mn | -7.79% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.15% |
| Mar 31, 2026 | 5.76% |
| Dec 31, 2025 | -17.15% |
| Sep 30, 2025 | 10.00% |
| Jun 30, 2025 | 11.83% |
| Mar 31, 2025 | 4.05% |
| Dec 31, 2024 | 8.73% |
| Sep 30, 2024 | 9.93% |
| Jun 30, 2024 | 15.90% |
| Mar 31, 2024 | 7.30% |
| Dec 31, 2023 | 13.99% |
| Sep 30, 2023 | 14.39% |
| Jun 30, 2023 | 13.16% |
| Mar 31, 2023 | 9.15% |
| Dec 31, 2022 | 16.25% |
| Sep 30, 2022 | 13.90% |
| Jun 30, 2022 | 17.78% |
| Mar 31, 2022 | 20.91% |
| Dec 31, 2021 | 16.09% |
| Sep 30, 2021 | 20.99% |